If money were no issue or if you were invited to have your genome sequenced free of charge and donate your anonymized data for biomedical research, would you do it?...Read More

High expectations, mounting interest by pharma and biotech investors, growing focus on value, and occasionally breathless news reporting. These are some of the artefacts that surround fast-moving developments in the...Read More